Ardelyx, Inc. | Wantstats

Company ProfileStandardSep 26, 2026

Ardelyx, Inc.

Company Profile Analysis

Book Demo Register Your Interest

Year Founded & Workforce

2007

75 Employees

Industry

Healthcare

Services

Pipeline for IBS-C

Ardelyx, Inc. Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Ardelyx, Inc. Overview

Company Headquarter: Delaware, US

Founded: 2007

Workforce: 75 Employees

Company Working:

Ardelyx, Inc. is a specialized biopharmaceutical company. It manufactures and sells disruptive medicines for the treatment of cardiorenal and gastrointestinal diseases. The lead product of the company is tenapanor, which has completed the Phase III clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as the Phase III clinical trial for the treatment of hyperphosphatemia.

Strategy

To develop therapeutics for cardiorenal and gastrointestinal diseasesThe company is involved in research and development for developing new treatments for gastrointestinal and cardiorenal diseases

Company Snapshot

$24M

Revenue

Employees

2007

Founded

SWOT Analysis

Strengths

Well-established product portfolio

Weaknesses

Limited presence in developing economies
Resolving liquidities of the company

Opportunities

Business expansion in the healthcare segment through investments in mergers and acquisitions

Threats

Fluctuating exchange rates
Government regulations for product approvals

Key Developments

Date	Approach	Development
–	Clinical Trials	The company submitted a new drug application to the US Food and Drug Administration of Tenapanor for IBS-C.
–	Agreement	The company entered into a license agreement with Shanghai Fosun Pharmaceutical Industrial Development Company Limited (Fosun Pharma) providing Fosun Pharma with exclusive rights to develop and commercialize tenapanor in China for the treatment of patients with hyperphosphatemia related to chronic kidney disease, as well as patients with IBS-C.
–	Agreement	The company entered into a license agreement with Kyowa Hakko Kirin Co., Ltd. for the development and commercialization of tenapanor in Japan.

Product Offering

Ardelyx, Inc.
- Pipeline for IBS-C

Financial Performance

Reports featuring Ardelyx, Inc.

One market report profiles this company.

Global Irritable Bowel Syndrome Treatment MarketHealthcare · Healthcare

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.

Get Contacts →

About the Author

Wantstats Research Team

Wantstats' research desk profiles Ardelyx, Inc. as part of our ongoing coverage of the Healthcare sector, drawing on public company data, filings, and market intelligence.

Powering the world's best teams.
From next-gen startups to established enterprises.

See our work in action

Start your data driven journey with us!

Book a Demo Now

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.